ID: ALA2324159

Max Phase: Preclinical

Molecular Formula: C21H33N3O3S

Molecular Weight: 407.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCS(=O)(=O)N1CCN(C2(CNC(=O)c3ccccc3)CCCCC2)CC1

Standard InChI:  InChI=1S/C21H33N3O3S/c1-2-17-28(26,27)24-15-13-23(14-16-24)21(11-7-4-8-12-21)18-22-20(25)19-9-5-3-6-10-19/h3,5-6,9-10H,2,4,7-8,11-18H2,1H3,(H,22,25)

Standard InChI Key:  TZGCIYBEOJISSX-UHFFFAOYSA-N

Associated Targets(Human)

Glycine transporter 1 2077 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycine transporter 2 697 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 407.58Molecular Weight (Monoisotopic): 407.2243AlogP: 2.48#Rotatable Bonds: 7
Polar Surface Area: 69.72Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.67CX LogP: 2.39CX LogD: 2.32
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.75Np Likeness Score: -1.47

References

1. Cioffi CL, Wolf MA, Guzzo PR, Sadalapure K, Parthasarathy V, Dethe D, Maeng JH, Carulli E, Loong DT, Fang X, Hu M, Gupta P, Chung M, Bai M, Moore N, Luche M, Khmelnitsky Y, Love PL, Watson MA, Mhyre AJ, Liu S..  (2013)  Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.,  23  (5): [PMID:23380375] [10.1016/j.bmcl.2013.01.006]

Source